Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRLBF Cresco Labs	$0.75 +0.5%	$0.90	$0.70 ▼ $2.60	$363.66M	1.79	608,689 shs	458,875 shs
CWBHF Charlotte's Web	$0.09 -3.5%	$0.11	$0.07 ▼ $0.27	N/A	N/A	167,585 shs	36,112 shs
GWPH GW Pharmaceuticals	$218.96	$218.59	$87.07 ▼ $219.57	$6.86B	2.15	899,771 shs	N/A
JAZZ Jazz Pharmaceuticals	$134.16 -2.0%	$128.92	$99.06 ▼ $148.06	$8.15B	0.44	776,983 shs	766,627 shs
MJ Amplify Alternative Harvest ETF	$20.57 +1.6%	$25.01	$19.89 ▼ $57.96	$118.69M	1.25	77,987 shs	77,946 shs
MJ Amplify Alternative Harvest ETF	$20.57 +1.6%	$25.01	$19.89 ▼ $57.96	$118.69M	1.25	77,987 shs	77,946 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRLBF Cresco Labs	+0.54%	-9.59%	-20.74%	-23.59%	-52.24%
CWBHF Charlotte's Web	0.00%	-12.54%	-15.97%	-17.81%	-41.94%
GWPH GW Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
JAZZ Jazz Pharmaceuticals	-1.97%	-4.33%	+8.62%	+8.54%	+15.86%
MJ Amplify Alternative Harvest ETF	+1.58%	-7.68%	-21.73%	-25.79%	-44.88%
MJ Amplify Alternative Harvest ETF	+1.58%	-7.68%	-21.73%	-25.79%	-44.88%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CRLBF Cresco Labs	2.9584 of 5 stars	3.4	5.0	0.0	0.0	2.5	0.0	1.3
CWBHF Charlotte's Web	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GWPH GW Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
JAZZ Jazz Pharmaceuticals	4.9103 of 5 stars	4.5	2.0	0.0	4.0	3.0	2.5	3.1
MJ Amplify Alternative Harvest ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MJ Amplify Alternative Harvest ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRLBF Cresco Labs	2.75	Moderate Buy	$2.50	235.57% Upside
CWBHF Charlotte's Web	0.00	N/A	N/A	N/A
GWPH GW Pharmaceuticals	0.00	N/A	N/A	N/A
JAZZ Jazz Pharmaceuticals	2.93	Moderate Buy	$190.53	42.02% Upside
MJ Amplify Alternative Harvest ETF	2.64	Moderate Buy	$20.57	N/A
MJ Amplify Alternative Harvest ETF	2.64	Moderate Buy	$20.57	N/A

Current Analyst Ratings Breakdown

Latest GWPH, JAZZ, CWBHF, CRLBF, MJ, and MJ Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/10/2025	JAZZ Jazz Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$200.00 ➝ $217.00
3/7/2025	JAZZ Jazz Pharmaceuticals	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight	$175.00 ➝ $183.00
3/7/2025	JAZZ Jazz Pharmaceuticals	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$145.00 ➝ $179.00
3/6/2025	JAZZ Jazz Pharmaceuticals	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$220.00 ➝ $230.00
3/5/2025	JAZZ Jazz Pharmaceuticals	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$210.00 ➝ $210.00
2/27/2025	JAZZ Jazz Pharmaceuticals	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$190.00 ➝ $200.00
2/26/2025	JAZZ Jazz Pharmaceuticals	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$140.00 ➝ $150.00
2/26/2025	JAZZ Jazz Pharmaceuticals	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$163.00 ➝ $176.00
2/26/2025	JAZZ Jazz Pharmaceuticals	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$179.00 ➝ $178.00
2/26/2025	JAZZ Jazz Pharmaceuticals	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$200.00 ➝ $209.00

(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRLBF Cresco Labs	$770.89M	0.47	$0.04 per share	18.48	$1.24 per share	0.60
CWBHF Charlotte's Web	N/A	N/A	N/A	N/A	N/A	N/A
GWPH GW Pharmaceuticals	$311.33M	22.05	$0.01 per share	18,588.22	$23.48 per share	9.33
JAZZ Jazz Pharmaceuticals	$4.07B	2.00	$27.32 per share	4.91	$59.36 per share	2.26
MJ Amplify Alternative Harvest ETF	N/A	N/A	N/A	N/A	N/A	N/A
MJ Amplify Alternative Harvest ETF	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRLBF Cresco Labs	-$175.52M	-$0.20	N/A	N/A	N/A	-9.15%	-16.52%	-4.81%	5/13/2025 (Estimated)
CWBHF Charlotte's Web	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
GWPH GW Pharmaceuticals	-$9.02M	-$0.24	N/A	608.22	N/A	-11.05%	-7.46%	-6.13%	N/A
JAZZ Jazz Pharmaceuticals	$414.83M	$8.79	18.90	7.17	1.04	11.60%	29.30%	9.72%	5/7/2025 (Estimated)
MJ Amplify Alternative Harvest ETF	N/A	N/A	16.72	∞	N/A	N/A	N/A	N/A	N/A
MJ Amplify Alternative Harvest ETF	N/A	N/A	16.72	∞	N/A	N/A	N/A	N/A	N/A

Latest GWPH, JAZZ, CWBHF, CRLBF, MJ, and MJ Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/21/2025	N/A	CRLBF Cresco Labs	-$0.02	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRLBF Cresco Labs	N/A	N/A	N/A	N/A	N/A
CWBHF Charlotte's Web	N/A	N/A	N/A	N/A	N/A
GWPH GW Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
JAZZ Jazz Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
MJ Amplify Alternative Harvest ETF	$0.18	0.88%	N/A	N/A	N/A
MJ Amplify Alternative Harvest ETF	$0.18	0.88%	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRLBF Cresco Labs	1.80	1.97	1.39
CWBHF Charlotte's Web	N/A	N/A	N/A
GWPH GW Pharmaceuticals	0.01	5.13	4.31
JAZZ Jazz Pharmaceuticals	1.46	4.26	3.74
MJ Amplify Alternative Harvest ETF	N/A	N/A	N/A
MJ Amplify Alternative Harvest ETF	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRLBF Cresco Labs	0.05%
CWBHF Charlotte's Web	N/A
GWPH GW Pharmaceuticals	81.00%
JAZZ Jazz Pharmaceuticals	89.14%
MJ Amplify Alternative Harvest ETF	N/A
MJ Amplify Alternative Harvest ETF	N/A

Insider Ownership

Company	Insider Ownership
CRLBF Cresco Labs	N/A
CWBHF Charlotte's Web	N/A
GWPH GW Pharmaceuticals	3.10%
JAZZ Jazz Pharmaceuticals	4.20%
MJ Amplify Alternative Harvest ETF	N/A
MJ Amplify Alternative Harvest ETF	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRLBF Cresco Labs	2,760	488.14 million	N/A	Not Optionable
CWBHF Charlotte's Web	260	N/A	N/A	Not Optionable
GWPH GW Pharmaceuticals	1,161	31.35 million	N/A	Optionable
JAZZ Jazz Pharmaceuticals	3,200	60.73 million	57.92 million	Optionable
MJ Amplify Alternative Harvest ETF	N/A	5.77 million	N/A	Not Optionable
MJ Amplify Alternative Harvest ETF	N/A	5.77 million	N/A	Not Optionable

GWPH, JAZZ, CWBHF, CRLBF, MJ, and MJ Headlines

Recent News About These Companies

Major Cannabis ETF Change

January 28, 2025 | newcannabisventures.com

Amplify ETFs Aligns Global and U.S. Cannabis Exposure Across MJ and CNBS

January 28, 2025 | markets.businessinsider.com

DEA marijuana rescheduling hearing cancelled following legal challenge

January 14, 2025 | msn.com

The Death of Another Cannabis ETF

January 9, 2025 | newcannabisventures.com

Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post

November 14, 2024 | msn.com

MJ Amplify Alternative Harvest ETF

October 18, 2024 | seekingalpha.com

ETFs to Track Amid Biden's Better Showing in Swing States

July 10, 2024 | zacks.com

Amplify U.S. Alternative Harvest ETF

May 7, 2024 | reuters.com

Thematic ETF Winners of the Q1 2024 Earnings Season

May 7, 2024 | etftrends.com

Cannabis industry views DEA news as a ‘positive step,’ but more work lies ahead

May 1, 2024 | crainscleveland.com

Cannabis ETFs Soar On Reports DEA Plans To Reclassify Marijuana

May 1, 2024 | forbes.com

Wall Street Breakfast: Change Comes Slowly

April 23, 2024 | seekingalpha.com

MJ: Over Diversified Cannabis ETF, But Still A Solid Pick

April 7, 2024 | seekingalpha.com

Top ETF Stories of March to Be Watched in April

April 3, 2024 | zacks.com

5 Top-Performing ETF Areas of Last Week

April 2, 2024 | zacks.com

5 Best ETF Areas of March

April 1, 2024 | zacks.com

5 Sector ETFs That Beat the Market in March

March 28, 2024 | zacks.com

ETF Themes That Dominated in Q1 2023

March 25, 2024 | etftrends.com

Best ETF Areas of Last Week

March 25, 2024 | msn.com

MJUS Amplify U.S. Alternative Harvest ETF

March 24, 2024 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GWPH, JAZZ, CWBHF, CRLBF, MJ, and MJ Company Descriptions

Cresco Labs OTCMKTS:CRLBF

$0.75 +0.00 (+0.54%)

As of 03/12/2025 03:59 PM Eastern

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

Charlotte's Web OTCMKTS:CWBHF

$0.09 0.00 (-3.54%)

As of 03/12/2025 03:46 PM Eastern

Charlotte's Web Holdings, Inc. is involved in the farming, manufacture, marketing, and sale of hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, ReCreate, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and Colorado State University's College of Agricultural Sciences; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. The company was founded in 2013 and is headquartered in Louisville, Colorado.

GW Pharmaceuticals NASDAQ:GWPH

GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. Its lead product is Epidiolex, an oral medicine for the treatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex. The company also develops and markets Sativex for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates for the treatment of schizophrenia, autism spectrum disorder, neuropsychiatric symptom, and neonatal hypoxic ischemic encephalopathy. It primarily operates in Europe, the United Kingdom, the United States, and internationally. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.

Jazz Pharmaceuticals NASDAQ:JAZZ

$134.16 -2.70 (-1.97%)

Closing price 03/12/2025 04:00 PM Eastern

Extended Trading

$135.62 +1.46 (+1.08%)

As of 03/12/2025 06:46 PM Eastern

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.

Amplify Alternative Harvest ETF NYSEARCA:MJ

$20.57 +0.32 (+1.58%)

As of 03/12/2025 04:10 PM Eastern

The ETFMG Alternative Harvest ETF (MJ) is an exchange-traded fund that is based on the Prime Alternative Harvest index. The fund tracks an index of global firms engaged in the legal cultivation, production, marketing or distribution of cannabis, cannabinoids or tobacco products. The portfolio is weighted by market cap or equally based on a proprietary system. MJ was launched on Dec 2, 2015 and is managed by ETF Managers Group.

Amplify Alternative Harvest ETF NYSEARCA:MJ

$20.57 +0.32 (+1.58%)

As of 03/12/2025 04:10 PM Eastern

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time